Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1992
Experimental antifungal chemotherapy in granulocytopenic animal models of disseminated candidiasis: approaches to understanding investigational antifungal compounds for patients with neoplastic diseasesT J Walsh, J W Lee, E Roilides, et al.Infection and Immunity|August 1, 1996
Specific induction of fibronectin binding activity by hemoglobin in Candida albicans grown in defined mediaS Yan, E Nègre, J A Cashel, et al.Antimicrobial Agents and Chemotherapy|September 15, 2001
Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma samplingA H Groll, D Mickiene, R Petraitiene, et al.Cytokine|January 1, 1996
Ex vivo effects of macrophage colony-stimulating factor on human monocyte activity against fungal and bacterial pathogensE Roilides, C A Lyman, S D Mertins, et al.Antimicrobial Agents and Chemotherapy|March 1, 1994
Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosisM C Allende, J W Lee, P Francis, et al.Antimicrobial Agents and Chemotherapy|September 3, 1999
Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbitsR Petraitiene, V Petraitis, A H Groll, et al.Cytokine|August 14, 2001
Recombinant human macrophage colony-stimulating factor augments pulmonary host defences against Aspergillus fumigatusC E Gonzalez, C A Lyman, S Lee, et al.Journal of Clinical Microbiology|June 2, 2000
Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasisT J Walsh, C E Gonzalez, S Piscitelli, et al.Antimicrobial Agents and Chemotherapy|February 13, 2001
Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasisV Petraitis, R Petraitiene, A H Groll, et al.Blood|November 1, 1988
Effects of recombinant human granulocyte-macrophage colony-stimulating factor on intracellular pH in mature granulocytesR Sullivan, J D Griffin, J Wright, et al.Pageof 3